The Medical Device Excise Tax - Over before It Begins?

and the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital (A.S.K.) - all in Boston.
New England Journal of Medicine (Impact Factor: 55.87). 04/2013; 368(19). DOI: 10.1056/NEJMp1304175
Source: PubMed


In June 2012, the Supreme Court upheld critical provisions of the Affordable Care Act (ACA), which aims to expand health insurance to many of the 50 million currently uninsured Americans. With prospects dimming for legislative reversal of the entire law, the various stakeholders in the health care market are now focusing on its implementation. One of the numerous controversial elements to date has been the medical device excise tax, a 2.3% tax on domestic sales of medical devices, paid by the manufacturer, which went into effect in January 2013. Several categories of device sales are exempted, including purchases by government . . .

6 Reads